These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 12407733)
1. Molecular alterations in lung cancer. Impact on prognosis. Kijima T; Maulik G; Salgia R Methods Mol Med; 2003; 75():29-38. PubMed ID: 12407733 [TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular biology of small cell lung cancer. Sattler M; Salgia R Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090 [TBL] [Abstract][Full Text] [Related]
3. [Research advance on molecular and cellular biology of small cell lung cancer]. Ji FY; Qian GS; Huang GJ Ai Zheng; 2005 Jul; 24(7):903-8. PubMed ID: 16004825 [TBL] [Abstract][Full Text] [Related]
4. EGFR activating aberration occurs independently of other genetic aberrations or telomerase activation in adenocarcinoma of the lung. Arifin M; Hiyama K; Tanimoto K; Wiyono WH; Hiyama E; Nishiyama M Oncol Rep; 2007 Jun; 17(6):1405-11. PubMed ID: 17487398 [TBL] [Abstract][Full Text] [Related]
5. A translational view of the molecular pathogenesis of lung cancer. Sato M; Shames DS; Gazdar AF; Minna JD J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807 [TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of small cell lung carcinoma. Wistuba II; Gazdar AF; Minna JD Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891 [TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of lung cancer. Sekido Y; Fong KM; Minna JD Annu Rev Med; 2003; 54():73-87. PubMed ID: 12471176 [TBL] [Abstract][Full Text] [Related]
10. The biology of lung cancer including potential clinical applications. Zöchbauer-Müller S; Minna JD Chest Surg Clin N Am; 2000 Nov; 10(4):691-708. PubMed ID: 11091920 [TBL] [Abstract][Full Text] [Related]
11. Telomerase activity significantly correlates with chromosome alterations, cell differentiation, and proliferation in lung adenocarcinomas. Fujiwara M; Okayasu I; Takemura T; Tanaka I; Masuda R; Furuhata Y; Noji M; Oritsu M; Kato M; Oshimura M Mod Pathol; 2000 Jul; 13(7):723-9. PubMed ID: 10912930 [TBL] [Abstract][Full Text] [Related]
12. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Osada H; Takahashi T Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883 [TBL] [Abstract][Full Text] [Related]
15. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling. Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159 [TBL] [Abstract][Full Text] [Related]
16. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo. Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238 [TBL] [Abstract][Full Text] [Related]